Raymond James & Associates Endra Life Sciences Inc. Transaction History

Raymond James & Associates

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 11, 2022	SELL	$0.36 - $0.77 $25,507 - $54,557	-70,854 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.69 - $1.73 $48,889 - $122,577	70,854 New	70,854 $49,000

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $398M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.